Leslie Calapre

1.3k total citations
39 papers, 892 citations indexed

About

Leslie Calapre is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Leslie Calapre has authored 39 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Leslie Calapre's work include Cancer Genomics and Diagnostics (22 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Cancer Cells and Metastasis (12 papers). Leslie Calapre is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Cancer Cells and Metastasis (12 papers). Leslie Calapre collaborates with scholars based in Australia, United States and Netherlands. Leslie Calapre's co-authors include Elin S. Gray, Mel Ziman, Michael Millward, Tarek Meniawy, Lydia Warburton, Du-Bois Asante, Michelle R. Pereira, Muhammad A. Khattak, Anna Reid and Ashleigh C. McEvoy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Leslie Calapre

39 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Calapre Australia 17 460 458 361 158 154 39 892
Lizhou Jia China 19 265 0.6× 433 0.9× 468 1.3× 224 1.4× 123 0.8× 45 968
David Killock United States 13 146 0.3× 344 0.8× 345 1.0× 214 1.4× 151 1.0× 211 879
Ludmilla de Plater France 13 249 0.5× 458 1.0× 405 1.1× 79 0.5× 125 0.8× 23 934
Andrea Pelosi Italy 18 300 0.7× 202 0.4× 489 1.4× 297 1.9× 43 0.3× 35 912
Salvatore A. Del Prete United States 10 154 0.3× 374 0.8× 307 0.9× 99 0.6× 99 0.6× 13 665
Lauren G. Aoude Australia 16 287 0.6× 434 0.9× 634 1.8× 200 1.3× 86 0.6× 29 1.0k
Jörn Dietrich Germany 20 242 0.5× 465 1.0× 706 2.0× 308 1.9× 187 1.2× 33 1.1k
William Rickaby United Kingdom 5 167 0.4× 454 1.0× 419 1.2× 106 0.7× 50 0.3× 14 702
Anita K. Mehta United States 12 162 0.4× 457 1.0× 442 1.2× 345 2.2× 118 0.8× 20 970
Melanie Janning Germany 14 208 0.5× 320 0.7× 266 0.7× 122 0.8× 122 0.8× 33 746

Countries citing papers authored by Leslie Calapre

Since Specialization
Citations

This map shows the geographic impact of Leslie Calapre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Calapre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Calapre more than expected).

Fields of papers citing papers by Leslie Calapre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Calapre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Calapre. The network helps show where Leslie Calapre may publish in the future.

Co-authorship network of co-authors of Leslie Calapre

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Calapre. A scholar is included among the top collaborators of Leslie Calapre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Calapre. Leslie Calapre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asante, Du-Bois, Ganendra Raj Mohan, Emmanuel Acheampong, et al.. (2023). Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients. Scientific Reports. 13(1). 2552–2552. 5 indexed citations
2.
Beasley, Aaron B., Leslie Calapre, Timothy Isaacs, et al.. (2023). Detection of metastases using circulating tumour DNA in uveal melanoma. Journal of Cancer Research and Clinical Oncology. 149(16). 14953–14963. 8 indexed citations
3.
Calapre, Leslie, Johnny Lo, Vikas Bhat, et al.. (2022). Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy. European Journal of Cancer. 172. 98–106. 22 indexed citations
4.
Lin, Weitao, Aaron B. Beasley, Nima Mesbah Ardakani, et al.. (2021). Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing. Australasian Journal of Paramedicine. 7(5). a006111–a006111. 17 indexed citations
5.
McEvoy, Ashleigh C., Michelle R. Pereira, Anna Reid, et al.. (2021). Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression. British Journal of Cancer. 126(3). 401–408. 23 indexed citations
6.
Asante, Du-Bois, Michael Morici, Ganendra Raj Mohan, et al.. (2021). Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients. Cancers. 13(24). 6225–6225. 12 indexed citations
7.
Beasley, Aaron B., Timothy Isaacs, Tersia Vermeulen, et al.. (2021). Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture. Cancers. 13(23). 5990–5990. 9 indexed citations
8.
Khattak, Muhammad Adnan, Tarek Meniawy, Anna Reid, et al.. (2021). Patient human leukocyte antigen (HLA) genotype may predict response to anti-programmed death receptor 1 (anti-PD1) in advanced melanoma.. Journal of Clinical Oncology. 39(15_suppl). e21512–e21512. 2 indexed citations
9.
Morici, Michael, Xin Hong, Ryan J. Sullivan, et al.. (2020). Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells. British Journal of Cancer. 122(7). 1059–1067. 48 indexed citations
10.
Warburton, Lydia, Tarek Meniawy, Leslie Calapre, et al.. (2020). Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma. Scientific Reports. 10(1). 18878–18878. 16 indexed citations
11.
Warburton, Lydia, Leslie Calapre, Michelle R. Pereira, et al.. (2020). Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression. Cancers. 12(11). 3486–3486. 11 indexed citations
12.
Johansson, Peter A., Michelle R. Pereira, Ashleigh C. McEvoy, et al.. (2020). The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies—Beyond BRAF Mutant Detection. Cancers. 12(12). 3793–3793. 16 indexed citations
13.
Calapre, Leslie, Johnny Lo, Samantha Bowyer, et al.. (2020). Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Journal for ImmunoTherapy of Cancer. 8(2). e001620–e001620. 36 indexed citations
14.
Calapre, Leslie, Johnny Lo, Samantha Bowyer, et al.. (2020). 301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy. Annals of Oncology. 31. S1359–S1360. 1 indexed citations
15.
Gray, Elin S., Michelle R. Pereira, Leslie Calapre, et al.. (2019). Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel. Journal of Molecular Diagnostics. 21(3). 418–426. 18 indexed citations
16.
Asante, Du-Bois, Leslie Calapre, Mel Ziman, Tarek Meniawy, & Elin S. Gray. (2019). Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?. Cancer Letters. 468. 59–71. 131 indexed citations
17.
McEvoy, Ashleigh C., Lydia Warburton, Leslie Calapre, et al.. (2018). Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients. BMC Cancer. 18(1). 726–726. 82 indexed citations
18.
Isaacs, Timothy, Aaron B. Beasley, Adnan Khattak, et al.. (2017). DETECTION OF CHROMOSOMAL ABERRATIONS ASSOCIATED WITH PROGNOSIS OF UVEAL MELANOMA USING CIRCULATING TUMOUR CELLS. Clinical and Experimental Ophthalmology. 45. 61–61. 1 indexed citations
19.
Gray, Elin S., Anna Reid, Samantha Bowyer, et al.. (2015). Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology. 135(8). 2040–2048. 64 indexed citations
20.
Calapre, Leslie, Elin S. Gray, & Mel Ziman. (2013). Heat stress: A risk factor for skin carcinogenesis. Cancer Letters. 337(1). 35–40. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhou Jia Breakdown of academic impact, for papers by David Killock Breakdown of academic impact, for papers by Ludmilla de Plater Breakdown of academic impact, for papers by Andrea Pelosi Breakdown of academic impact, for papers by Salvatore A. Del Prete Breakdown of academic impact, for papers by Lauren G. Aoude Breakdown of academic impact, for papers by Jörn Dietrich Breakdown of academic impact, for papers by William Rickaby Breakdown of academic impact, for papers by Anita K. Mehta Breakdown of academic impact, for papers by Melanie Janning
Rankless by CCL
2026